218 related articles for article (PubMed ID: 18663578)
21. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
22. Overcoming drug resistance in patients with metastatic breast cancer.
Wong ST; Goodin S
Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
[TBL] [Abstract][Full Text] [Related]
23. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
24. Applications of nanotechnology in cancer.
Johnson L; Gunasekera A; Douek M
Discov Med; 2010 Apr; 9(47):374-9. PubMed ID: 20423682
[TBL] [Abstract][Full Text] [Related]
25. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
Halterman PA
Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic strategies for breast cancer based on histological type.
Akiyama F; Horii R
Breast Cancer; 2009; 16(3):168-72. PubMed ID: 19479319
[TBL] [Abstract][Full Text] [Related]
27. New frontiers in nanotechnology for cancer treatment.
Alexis F; Rhee JW; Richie JP; Radovic-Moreno AF; Langer R; Farokhzad OC
Urol Oncol; 2008; 26(1):74-85. PubMed ID: 18190835
[TBL] [Abstract][Full Text] [Related]
28. Neurosurgery in the realm of 10(-9), part 1: stardust and nanotechnology in neuroscience.
Elder JB; Liu CY; Apuzzo ML
Neurosurgery; 2008 Jan; 62(1):1-20. PubMed ID: 18300888
[TBL] [Abstract][Full Text] [Related]
29. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy.
Guarneri V; Conte P
Oncologist; 2009 Jul; 14(7):645-56. PubMed ID: 19608638
[TBL] [Abstract][Full Text] [Related]
30. High-resolution noncontact atomic force microscopy.
Pérez R; García R; Schwarz U
Nanotechnology; 2009 Jul; 20(26):260201. PubMed ID: 19531843
[TBL] [Abstract][Full Text] [Related]
31. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
Roy V; Perez EA
Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy for locally advanced breast cancer.
Specht J; Gralow JR
Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
[TBL] [Abstract][Full Text] [Related]
33. Emerging nanopharmaceuticals.
Bawarski WE; Chidlowsky E; Bharali DJ; Mousa SA
Nanomedicine; 2008 Dec; 4(4):273-82. PubMed ID: 18640076
[TBL] [Abstract][Full Text] [Related]
34. [Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?].
Fourquet A; Kirova Y; Bollet MA; Tournat H; Dendale R; Campana F
Cancer Radiother; 2008 Nov; 12(6-7):554-8. PubMed ID: 18838328
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer therapy: the role of PET-CT in decision making.
Pons F; Duch J; Fuster D
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
[TBL] [Abstract][Full Text] [Related]
36. Use of magnetic nanoparticle heating in the treatment of breast cancer.
Hilger I; Hergt R; Kaiser WA
IEE Proc Nanobiotechnol; 2005 Feb; 152(1):33-9. PubMed ID: 16441156
[TBL] [Abstract][Full Text] [Related]
37. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
Medina PJ; Goodin S
Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer: from the earliest times through to the end of the 20th century.
Ekmektzoglou KA; Xanthos T; German V; Zografos GC
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):3-8. PubMed ID: 19394749
[TBL] [Abstract][Full Text] [Related]
39. The evolution of targeted biologic therapies.
Sledge GW
Breast; 2007 Dec; 16 Suppl 2():S1-3. PubMed ID: 17703940
[TBL] [Abstract][Full Text] [Related]
40. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
Elder JB; Liu CY; Apuzzo ML
Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
